Tata Medical and Diagnostics Ltd (TataMD), the healthcare venture from Tata Group has launched the Tata MD check, which is probably India’s first and probably the largest COVID19 diagnostic kit. This kit has been built in association with CSIR- IGIB and is built on top of a CRISPR Cas 9 for COVID19 testing. The algorithm, incidentally, is called Feluda. Very interesting to note that it might be in reference to the detective character created by Satyajit Ray.
It took about 100 days for Tata MD,for its licencing and commercial launch. And also, it has been approved by the Indian Council of Medical Research (ICMR) and the DGCI and will be available through our diagnostic centres in India. It’s a paper based test with the image based visual readout. The reaction time is about 45 minutes, and the total testing time is about 75 minutes only because it’s from an mRNA extracted sample. There is high scalability. About 1 million of these test kits will be produced in a month from the Tata diagnostic and Research Centre outside of Chennai in Tamil Nadu.
Also, there is an AI based reporting tool that will help authorities keep track of traceability of samples and the results will be accessible from anywhere. And it. This test will allow from and massive rapid adoption potential to the far away regions of the country. It will be interesting to see how this pans out considering the seem to be close to good testing we seem to be close to a good vaccine and we seem to be good, close to a good protocol. Let’s see how things go from here.